Chronic Kidney Disease
The European label for Ozempic will be updated to include risk reduction for events related to kidney disease.
The NCQA awarded Interwell Health a Population Health Program Accreditation for its Interwell 360 program for those with CKD.
Vlado Perkovic spoke about findings from the FLOW, APPLAUSE-IgAN, and CREDENCE trials presented at ASN Kidney Week.
Researchers studied the associations between the timing of a patient’s first cigarette and the risk of CKD.
A study tested whether a urine acid/base score using both using urinary pH and NH4+could better predict CKD progression.
A study examined an association between hyperglycemic crises at diabetes diagnosis and a higher risk of developing CKD.
A study assessed the relationship between CKD and osteoarthritis, which share several similar risk factors.
Researchers compared incidence of mortality and kidney failure between patients with CKD and rare kidney diseases.
The FDA recalled a batch of Dr. Reddy’s Cinacalcet Tablets, a treatment for chronic kidney disease (CKD).
Novo Nordisk will terminate development of ocedurenone for treatment of hypertension in chronic kidney disease.
Drug stewardship to ensure the safety and effectiveness of medications is especially important in patients with CKD.
A study examined gestational exposure to maternal systemic glucocorticoids and risk of developing CKD in childhood.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.